申请人:Novo Nordisk A/S
公开号:US06303620B1
公开(公告)日:2001-10-16
Disclosed are 4,4-disubstituted and 3,3-disubstituted piperidine compounds of formula I
wherein D, E, G, J, R1, a, b, c, and d are defined in the specification, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone.
本发明涉及一种公式I的4,4-二取代和3,3-二取代哌啶化合物,其中D、E、G、J、R1、a、b、c和d在说明书中有定义,包含它们的组合物以及它们用于治疗由生长激素缺乏引起的医学疾病的用途。